他汀类药物非降脂作用研究新进展(2)
[6] Kothe H， Dalhoff K Rupp J, et al. HMG-CoA reductase inhibitors modify the in flammatory response of human macrophage and endothelial cells infected with Chlamydia pneumoniac. Circulation,2000,101:1760.
[7] 董砚奉，张秀英. 他汀类药物非降脂作用临床研究. 中国社区医师，2008，3(5)：160-163.
[8] Thom sen RW, Hundborg HH, Johnsen SP, et al. Statin use and mortality within 180 days after bacteremia A population-based cohort study.Cirt Care Med,2006,34(4):1080-1086.
[9] Wayman NS, Ellis BL, Thiemermann C. Simvastatin reduces infarct size in a model of acute myocardial ischemia and reperfusion in the rat. Med Sci Monit, 2003,9(5):BR155-9.
[10] Khalid Almuti, Rola Rimawi, Daniel Spevack, et al.Effects of statins beyond lipid lowering: potential for clinical benefits. int J Cardiol,2006, 109(1):7-15.
[11] Marshall， Sally M. The podocyte： a potential therapeutic tapget in diabetic nephropathy. Current Pharmaceutical Design，2007，13(26)：2713-2720.
[12] Hofmann JA， Kafatos FC， Janeway CA， et al. Phylogenic perspective in innate immunity. Science，1999,284(5418)：1313-1318.
, 百拇医药(赵兰蒂 杨建彬 王中良)
[7] 董砚奉，张秀英. 他汀类药物非降脂作用临床研究. 中国社区医师，2008，3(5)：160-163.
[8] Thom sen RW, Hundborg HH, Johnsen SP, et al. Statin use and mortality within 180 days after bacteremia A population-based cohort study.Cirt Care Med,2006,34(4):1080-1086.
[9] Wayman NS, Ellis BL, Thiemermann C. Simvastatin reduces infarct size in a model of acute myocardial ischemia and reperfusion in the rat. Med Sci Monit, 2003,9(5):BR155-9.
[10] Khalid Almuti, Rola Rimawi, Daniel Spevack, et al.Effects of statins beyond lipid lowering: potential for clinical benefits. int J Cardiol,2006, 109(1):7-15.
[11] Marshall， Sally M. The podocyte： a potential therapeutic tapget in diabetic nephropathy. Current Pharmaceutical Design，2007，13(26)：2713-2720.
[12] Hofmann JA， Kafatos FC， Janeway CA， et al. Phylogenic perspective in innate immunity. Science，1999,284(5418)：1313-1318.
, 百拇医药(赵兰蒂 杨建彬 王中良)